参考文献/References:
［1］KAZANDI M, ZEYBEK B, TEREK M C, et al. Grade 2 endometrioid adenocarcinoma an sing from adenomyosis of the uterus report of a case ［J］. European Journal of Gynaecological Oncology, 2010, 31(6): 719-721.
［2］Kobayashi, Hiroshi. Pathogenesis and malignant transformation of adenomyosis (Review) ［J］. Oncology Reports, 2012，29（3）：861-867.
［3］Hsu M I， Chou S Y， Lin S E， et al. Very early stage adenocarcinoma arising from adenomyosis in the uterus ［J］. Taiwanese Journal of Obstetrics ＆ Gynecology, 2006, 45(4):346-349.
［4］Colman H I,Rosenthal A H.Carcinoma developing in areas of adenomyosis ［J］. Obstetrics & Gynecology, 1959, 14(14):342-348.
［5］Ismiil N D， Rasty G， Ghorab Z， et al. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma ［J］. International Journal of Gynecological Pathology, 2007, 26(3):278-283.
［6］MATSUO K, MOEINI A, MACHIDA H, et al. Tumor characteristics and survival outcome of endometrial cancer arising in adenomyosis: an exploratory analysis ［J］. Annals of Surgical Oncology, 2016, 23(3): 959-967.
［7］ISMIIL N, RASTY G, GHORAB Z, et al. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion ［J］. Modern Pathology, 2007, 11(4): 252-257.
［8］KOSHIYAMA M, OKAMOTO T, UETA M. The relationship between endometrial carcinoma and coexistent adenomyosis uteri,endometriosis externa and myoma uteri ［J］.Cancer Detection and prevention,2003,28(2): 94-98.
［9］TANEICHI A, FUJIWARA H, TAKAHASHI Y A, et al. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma ［J］. International Journal of Gynecological Cancer, 2014, 24(8): 1429-1433.
［10］GENC M, GENC B, CENGIZ H. Adenomyosis and accompanying gynecological pathologies ［J］. Archives of Gynecology and Obstetrics, 2015, 291(4): 877-881.
［11］BABA A, YAMAZOE S, DOGRU M, et al. Clear cell adenocarcinoma arising from adenomyotic cyst: A case report and literature review ［J］. Journal of Obstetrics and Gynaecology Research, 2016, 42(2): 217-223.
［12］Lu B,Chen Q,Zhang X,et al. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases ［J］. Diagnostic Pathology, 2016, 11(1):46.
［13］Izadi-Mood, N Samadi,S Sarmadi, et al. Papillary serous carcinoma arising from adenomyosis presenting as intramural leiomyoma ［J］. Archives of Iranian Medicine, 2007, 10(2):258-260.
［14］MATSUO K, CAHOON S S, GUALTIERI M, et al. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer ［J］. Annals of Surgical Oncology, 2014, 21(13): 4246-4255.
［15］Goumenou AG, Arvan DA, Matalliotaskis IM, et at.Loss of heterozygosity in adenomysis on hMLHI,P16Ink4 and GALT loai［J］.Interational Journal of Mole cular Medicine, of Molecular Medicine, 2000,6(6):667-671.
［16］REBECCA K JONES R F, JUDITH N. BUlmer,apoptosis and bcl-2 experession in mormal hunman endometrium,endometiosis ang adenomyosis ［J］. Human Reproduction, 1998, 3(2): 3496-3502.
［17］NIE Ji-chan, LIU Xi-shi, GUO Sun-wei. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent ［J］. Reproductive Sciences, 2010, 17(11): 995-1005.
［18］TAKEUCHI K, YAMANAKA Y, HAMANA S, et al. Invasive adenocarcinoma arising from uterine adenomyosis involving the rectosigmoid eolon ［J］. 1Int J Gynecol Cancer, 2004, 14(5): 1004-1006.
［19］Motohara K， Tashiro H， Ohtake H， et al. Endometrioid adenocarcinoma arising in adenomyosis: elucidation by periodic magnetic resonance imaging evaluations ［J］. International Journal of Clinical Oncology, 2008, 13(3):266-270.
［20］VERIT F F, ENDOMETRIOSIS Y O. Leiomyoma and adenomyosis:the risk of gynecologic malignancy ［J］. Asian Pae J Cancer Prev, 2013, 14(10): 5589-5597.
［21］KUCERA E, HEJDA V, DANKOVCIK R, et al. Malignant changes inadenomyosis in patients with endometrioid adenocarcinoma ［J］. Eur JGynaecol Oncol,2011, 32(2): 182-184.
［22］Puppa G， Shozu M， Perin T， et al. Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report ［J］. Bmc Cancer, 2007, 7:103.
［23］LIU C H, CHANG W H, LIU Wei-min, et al. Serous carcinoma arising from adenomyosis ［J］. Taiwanese Journal of Obstetrics & Gynecology, 2017, 56(5): 706-707.
［24］李东林，梁文通．子宫腺肌病的特殊类型及恶变的诊治 ［J］．中国实用妇科与产科杂志，2017，33（2）：160-163．
［25］王海静，王悦，祝洪澜，等．子宫腺肌病恶变9例临床病理分析 ［J］．中国妇产科临床杂志，2017，5（5）：388-391．
相似文献/References:
[1]白莎莎,庞义存,田腊梅,等.Maspin蛋白在葡萄胎恶变中的作用[J].中国计划生育和妇产科,2011,(06):0.
BAI Sha-sha,PANG Yi-cun,TIAN La-mei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(4):0.
[2]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[3]苏慧明,徐燕,黎颖雄,等.诺舒子宫内膜去除术治疗子宫腺肌病致月经过多的临床研究[J].中国计划生育和妇产科,2014,(03):0.
SU Hui-ming,XU Yan,LI Ying-xiong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[4]毛世华,谭晓燕,范玲,等.高强度聚焦超声联合米非司酮治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
MAO Shi-hua,TAN Xiao-yan,FAN Ling,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[5]邓淑珍.曼月乐宫内节育器治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
DENG Shu-zhen,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[6]王宇慧,魏绍斌.中成药治疗子宫内膜异位症和子宫腺肌病的辨证应用[J].中国计划生育和妇产科,2015,(02):0.
[7]邓云,丁惠,许永华,等.高强度聚焦超声治疗子宫腺肌病病灶消融率影响因素分析[J].中国计划生育和妇产科,2015,(06):0.
DENG Yun,DING Hui,XU Yong-hua,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(4):0.
[8]孙馥箐,段华,叶红,等.双子宫畸形伴双侧子宫腺肌病与左侧子宫肌瘤1例并文献复习[J].中国计划生育和妇产科,2016,(04):0.
[9]李金皎,段华,汪沙,等.子宫腺肌病患者子宫肌层平滑肌细胞生长状态与增殖特点的研究[J].中国计划生育和妇产科,2016,(05):0.
LI Jin-jiao,DUAN Hua,WANG Sha,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(4):0.
[10]李晓欣,张萍,张纯溪,等.促性腺激素释放激素激动剂联合腹腔镜手术治疗大子宫腺肌病疗效的研究[J].中国计划生育和妇产科,2016,(07):0.
LI Xiao-xin,Zhang Ping,Zhang Chun-xi,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(4):0.